- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tasly Pharmaceutical Group Co Ltd (600535)
Track today's live Tasly (600535) share price, performance and key data on this page with our current Shanghai:600535 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Tasly share price on the Shanghai exchange. Use the dropdown to switch exchange for the 600535 share price, head to our technical summary section, which provides analysis on Tasly share price buy/sell indicators using real-time data (or discuss the Tasly (600535) stock price today with other investors in the Tasly SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS:600535 share price (ISIN: CNE000001C81) to enhance your trading decisions with our free investment tools and resources.
What Is the Tasly Pharmaceutical Group Co Ltd Share Price Today?
The Tasly share price today is 14.00.
What Is the Stock Symbol for Tasly Pharmaceutical Group Co Ltd
The stock symbol (or 'ticker') for Tasly Pharmaceutical Group Co Ltd is "600535."
What Stock Exchange Does Tasly Pharmaceutical Group Co Ltd Trade On?
Tasly Pharmaceutical Group Co Ltd is listed and trades on the Shanghai stock exchange.
Is Tasly Pharmaceutical Group Co Ltd a Good Stock to Buy?
Determining whether Tasly (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current SS:600535 share price (ISIN: CNE000001C81) to enhance your trading decisions with our free investment tools and resources.
What Is the Tasly Pharmaceutical Group Co Ltd Share Price Today?
The Tasly share price today is 14.00.
What Is the Stock Symbol for Tasly Pharmaceutical Group Co Ltd
The stock symbol (or 'ticker') for Tasly Pharmaceutical Group Co Ltd is "600535."
What Stock Exchange Does Tasly Pharmaceutical Group Co Ltd Trade On?
Tasly Pharmaceutical Group Co Ltd is listed and trades on the Shanghai stock exchange.
Is Tasly Pharmaceutical Group Co Ltd a Good Stock to Buy?
Determining whether Tasly (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Shanghai
Currency in CNY
14.00
+0.26(+1.89%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.72
14.10
52 wk Range
12.90
16.24
600535 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.7214.10
52 wk Range
12.9016.24
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600535 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
17.29
Upside
+23.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Tasly Pharmace receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Tasly Pharmace receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 17.29
(+23.50% Upside)
Earnings
Latest Release
22/08/2026
EPS / Forecast
0.35 / 0.35
Revenue / Forecast
2.04B / --
Compare 600535 to Peers and Sector
Metrics to compare | 600535 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600535PeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.1x | 18.6x | −0.3x | |
PEG Ratio | 1.24 | 0.60 | 0.00 | |
Price/Book | 1.6x | 2.2x | 2.6x | |
Price / LTM Sales | 2.6x | 2.2x | 3.0x | |
Upside (Analyst Target) | 23.5% | 35.6% | 58.6% | |
Fair Value Upside | Unlock | 17.2% | 8.4% | Unlock |
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Tasly (Shanghai: 600535) Share Price Today?
The Tasly stock price today is 14.00 CNY.
What Stock Exchange Does Tasly (600535) Trade On?
Tasly is listed and trades on the Shanghai Stock Exchange.
What Is the Ticker (Stock Symbol) for Tasly?
The stock symbol (also called a 'ticker') for Tasly is "600535."
Does Tasly Pay Dividends? What’s The Current 600535 Dividend Yield?
Yes, 600535 Pays Dividends to its Shareholders. The current Tasly dividend yield is 2.21%.
What Is the Current Tasly Market Capitalisation?
As of today, Tasly (Shanghai: 600535) market cap is 20.92B CNY.
What Is Tasly's (600535) Earnings Per Share (TTM)?
The Tasly EPS is currently 0.82 (Trailing Twelve Months).
When Is the Next Tasly Earnings Date?
Tasly's next earnings report will be released on 24/10/2026.
Is 600535 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Tasly moving averages and other technical indicators, the daily buy/sell signal for 600535 stock is Sell.
How Many Times Has Tasly Stock Split?
Tasly has split 4 times. (See the 600535 stock split history page for full effective split date and price information.)
How Many Employees Does Tasly Have?
Tasly has 10563 employees, based on their latest Companies House report.
What is the current trading status of Tasly (Shanghai: 600535)?
As of 03/10/2026, Tasly (600535) is trading at a share price of 14.00 CNY, with a previous close of 14.00 CNY. The stock has fluctuated within a day range of 13.72 CNY to 14.10 CNY, while its 52-week range spans from 12.90 CNY to 16.24 CNY.
What Is Tasly (600535) Price Target According to Analysts?
The average 12-month price target for Tasly is 17.29 CNY, with a high estimate of 18 CNY and a low estimate of 14.8 CNY. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +23.50% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.